AN1 (ASX) Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received

Originally posted by retiredyoung: ↑

Biotechs Are Battling to Make the First Good Blood Test For Covid-19

Antibody tests are at the forefront of a push to assess who has potentially built up some immunity.

Once a test is made, the hard part comes—proving that it actually works. To do so, researchers check how the test performs when looking at two categories of blood: some that’s Covid-19 positive, and some that they know isn’t.

If a test can reliably identify positive samples, it’s considered highly sensitive. If it can identify negatives, it’s called specific. That means it knows the difference between Covid-19 antibodies and others raised by, say, another coronavirus that causes the common cold.

“If your test can survive all that and give the accurate result, your lab is going to make an awful lot of money”

https://www.bloomberg.com/news/articles/2020-04-17/coronavirus-tests-biotechs-battle-to-make-first-good-blood-test

Expand

Has anybody with an ear to the ground heard if Cellmid's Wondfo POC Test is involved in all the test test testing going on...Mining Camps, Airlines, Aged Care Facilities, GP Surgeries, etc, etc?

Originally posted by ngunity: ↑

I hold and am glad to do so. In this modern era of 24x7 news it seems everyone is keen to breeze past the status quo, assume the cure is near at hand and invest in that future state.

I don't agree. Many of the articles I read these days talk about the status quo without rose tinted glasses and the consensus is 'testing, testing, testing'.

I don't believe CDY would be stupid enough to start selling a bad testing product into the market so, if and when they do announce their first round of sales and a follow on order for millions more dollars worth of that same test they are successfully selling, I'm going to read that as A) tests are good enough and B) since there's a huge demand for testing even in countries that are controlling C-19, that sales should be good for a while longer.

Expand

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

The winners & losers on market if negative gearing were gone

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ESR

(20min delay)
Last 0.8¢		Change 0.000(0.00%)		Mkt cap ! $3.690M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received, page-342

ACCC seeks Olam divestments before it can buy Namoi Cotton

The winners & losers on market if negative gearing were gone

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Featured News

Featured News

Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received, page-342

Top Stories

ACCC seeks Olam divestments before it can buy Namoi Cotton

The winners & losers on market if negative gearing were gone

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Featured News

Featured News